and cats when applying the abdominal fluid score (AFS) during AFAST. Note the algorithm assumes the patient is noncoagulopathic or, when coagulopathic, the coagulopathy is corrected.
Source: Reproduced with permission of Dr Gregory Lisciandro, Hill Country Veterinary Specialists and FASTVet.com, Spicewood, TX.
Postinterventional Trauma
Apply the “small‐volume bleeder versus large‐volume bleeder” principle to determine if the case is medical or surgical. The postinterventional patient includes any invasive procedure in which internal bleeding is a possible complication, such as percutaneous aspirations, needle and Tru‐Cut biopsy, laparoscopy, exploratory laparotomy, etc.
Small‐Volume AFS 1 and 2 Bleeders
In general, the “small‐volume bleeder” (AFS 1 and 2; modified AFS system <3) is not immediately surgical and serial AFAST with an assigned AFS is an important monitoring tool for detecting increasing AFS often before overt decompensation, referred to as the “crump” (Bilello et al. 2011).
In stable AFS 1 and 2 (modified AFS system <3) patients, the author routinely repeats AFAST with an assigned AFS ~1 hour post admission and then again four hours post admission, and then as clinical course dictates.
AFAST with an assigned AFS should continue during patient rounds every 12–24 hours or during recheck examination until ascites resolution, that is, AFS returns to 0, negative.
In questionable or unstable patients, serial AFAST with an assigned AFS are performed as often as necessary. The Global FAST approach is important to rule in and rule out other internal sites of bleeding and comorbidities in the thorax, including heart and lung.
Large‐Volume AFS 3 and 4 Bleeders (AFS ≥3)
In general, postinterventional bleeding in noncoagulopathic patients will not stop without a surgical intervention, in other words, the ligation of the bleeder(s). Many “large‐volume bleeders” are not initially anemic in the acute setting because patients can compensate, especially dogs which have a unique large splenic blood reservoir.
AFS 3 and 4 (modified AFS system ≥3) initially or on serial examinations are “large‐volume bleeders” and in general should be explored or have another appropriate intervention to stop the bleeding as soon as possible, with the caveat that the patient has an acceptable coagulation profile.
The author follows the axiom “If it's an AFS of 3 or 4, you should explore (surgically intervene),” with the caveat that the patient has an acceptable coagulation profile.
Pearl: Waiting on a compensated postinterventional noncoagulopathic “large‐volume bleeder” (AFS ≥3) instead of surgically addressing the cause of bleeding often leads to increased morbidity and cost (e.g., transfusion products) and increased patient anesthetic risk, because “large‐volume bleeders” predictably become markedly to severely anemic and overtly decompensate in time. Thus, “If it's an AFS of 3 or 4, you should explore (surgically intervene),” with the caveat that the patient has an acceptable coagulation profile.
Nontrauma
Nontraumatic hemoabdomen requires a more cerebral approach and knowledge base. Coagulopathy should always be ruled out, including minimally performing basic testing of prothrombin time (PT), activated partial thromboplastin time (aPTT), and a buccal mucosal or nail clip bleed time (platelet function test), readily available onsite tests at most practices. In coagulopathic cases, the coagulopathy generally needs to be corrected before invasive procedures. In noncoagulopathic cases, a bleeding mass is most common in dogs and cats and surgical intervention is required for definitive care. However, canine anaphylaxis must also be considered in all dogs with hemorrhagic effusions, some of which may have PT and aPTT times of <25% over the upper reference range, and thus not significantly coagulopathic (Lisciandro 2016b; Hnatusko et al. 2019). Because of this newly described complication in dogs, a focused spleen is now recommended following the AFAST examination in all canine hemoabdomens, and in general following any AFAST examinations in both dogs and cats (see Chapter 6 and Figure 6.35. See also canine anaphylaxis and gallbladder wall edema section within this chapter).
The focused spleen is a rule‐in test, meaning that when a mass is detected, it is probably real (see Figure 6.35). In contrast, if a splenic mass is not seen then it could have been missed, depending on the proficiency of the sonographer and location of the mass. Thus, the focused spleen examination should be considered as it has high specificity as a screening test, but with variable sensitivity. The focused spleen is helpful because when a cavitated midabdominal mass is detected, especially when associated with the spleen and deforming its capsule, such a finding raises the probability of being correct in concluding that the hemoabdomen is due to a bleeding mass (surgical management) rather than canine anaphylaxis (medical management) (Lisciandro 2014a, 2016b). Any mass that deforms the capsule of the spleen should be considered a serious finding.
Pearl: In contrast to dogs, cats with spontaneous nontraumatic hemoabdomen have a poor prognosis because the cause is likely advanced forms of neoplasia (Mandell and Drobatz 1995; Culp et al. 2010). However, the AFAST‐applied AFS is helpful in predicting degree of anticipated anemia, the need for blood transfusion and exploratory laparotomy, or other hemostatic interventions. The Global FAST approach may also be used to stage the feline.
Major AFAST Difference Between Blunt and Penetrating Trauma
There is a major difference that must be understood when applying AFAST to blunt and penetrating trauma. The difference lies in the behavior of blood. In blunt trauma, it generally doesn't matter where the patient bleeds as mesothelial cells lining the abdominal cavity, pleural cavity, and pericardial sac rapidly defibrinate blood, making it readily apparent on AFAST as free fluid (anechoic triangulations). In contrast, victims of penetrating trauma have ripping, tearing and crushing of tissue, especially with bite wounds, and hence blood clots. During AFAST, clotted blood is often difficult to discriminate from adjacent soft tissue and thus is often initially missed (Figure 7.6). Although there are no large veterinary studies (Lisciandro et al. 2008, 2009; Lisciandro 2012), the importance is likely similar to that in human medicine (Udobi et al. 2001), in that FAST is likely highly specific for surgical trauma but variably sensitive. AFAST (and Global FAST) should still be used as a first‐line screening test because of all the clinical questions that may be answered regarding the patient. However, in instances of a negative AFAST, serial examinations should be implemented as standard of care until it is clear whether the patient is surgical versus medical.
In time, clotted blood will defribinate and appear as free fluid, and when viscus organ injury is present, likely the organ will “leak” into the abdominal cavity. Thus, AFAST carries the potential to detect septic peritonitis and other developing complications earlier in their course. In fact, vascular injury, uroabdomen, bilioabdomen, gastrointestinal injury, and others may present over the next several days post injury. Parenchymal injury is also possible and the use of color
